文献速递脑血管病

急性缺血性卒中EQ-5D-5L的差异项目功能评估:ACT试验证据

Evaluating Differential Item Functioning in EQ-5D-5L in Acute Ischemic Stroke: Evidence From the ACT Trial.
PubMed 文献 · Stroke · 2026-07-23

本研究基于ACT试验(阿替普酶对比替奈普酶)数据,评估急性缺血性卒中患者90天EQ-5D-5L的差异项目功能(DIF)。结果显示仅年龄组存在显著DIF(χ2=86.9,P<0.001),但仅自护和日常活动呈中等效应,且有无DIF调整的因子得分高度相关(r=0.98),提示该量表在性别和治疗组间功能等效。

要点

  • EQ-5D-5L在卒中患者性别和治疗组间未见显著DIF。
  • 年龄组DIF仅见于自护(sWABC=-0.46)和日常活动(sWABC=-0.34)两项。
  • DIF调整与否的因子得分相关性达0.98,实际影响有限。

核心结论

  • EQ-5D-5L在急性缺血性卒中人群中跨性别和治疗组功能等效,年龄相关DIF对个体得分实际影响小。

研究设计与样本

  • 基于ACT试验(阿替普酶对比替奈普酶)的注册随机对照研究,纳入加拿大22个卒中中心2019年12月至2022年1月发病4.5小时内符合溶栓条件的急性缺血性卒中患者。
  • 1577例入组患者中1264例存活至90天且EQ-5D-5L数据完整(51.2%替奈普酶,46.5%女性,30.1%年龄≥80岁)。
  • 采用多组等级反应模型和Wald-based sweep程序评估DIF,以sWABC量化效应大小。

主要发现

  • 总体检验仅年龄组显示显著DIF(χ2=86.9,P<0.001),性别(χ2=31.7,P=0.063)和治疗组(χ2=22.4,P=0.379)无显著DIF。
  • 年龄相关DIF涉及自护、日常活动、疼痛/不适和焦虑/抑郁四项,但仅自护(sWABC=-0.46)和日常活动(sWABC=-0.34)呈中等效应。
  • 疼痛/不适(sWABC=-0.002)和焦虑/抑郁(sWABC=0.09)的DIF效应可忽略。
  • 有无DIF调整的模型因子得分相关系数为0.98。

关键数值与推荐

  • |sWABC|<0.10定义为可忽略的DIF效应。
  • 自护和日常活动的年龄相关DIF呈中等效应(sWABC分别为-0.46和-0.34)。

临床怎么用

  • EQ-5D-5L可用于卒中试验中跨性别和治疗组的健康相关生活质量比较。
  • 年龄相关DIF主要影响躯体功能条目,但对个体得分实际影响有限,解读时需留意。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Health-related quality of life is a key secondary end point in stroke trials. Differential item functioning (DIF) occurs when individuals with the same underlying health-related quality of life interpret and respond differently to questionnaire items, potentially biasing treatment comparisons. This study evaluates DIF in the patient-reported 5-level EuroQOL questionnaire among patients with acute ischemic stroke across age, sex, and treatment groups. METHODS: Data were from the AcT trial (Alteplase Compared to Tenecteplase), a registry-based randomized comparison of alteplase and tenecteplase conducted at 22 stroke centers across Canada (December 2019-January 2022). Patients with acute ischemic stroke presenting within 4.5 hours of symptom onset and eligible for thrombolysis completed the 5-level EuroQOL questionnaire at 90 days poststroke. DIF was assessed using multigroup graded response models with the Wald-based sweep procedure, which accounts for between-group differences in latent trait distributions. We quantified effect sizes using signed weighted area between curves (sWABC); |sWABC| <0.10=negligible. RESULTS: Of 1577 patients enrolled in the trial, 1264 survived to 90 days with complete 5-level EuroQOL questionnaire data (51.2% tenecteplase; 46.5% female; 30.1% aged ≥80). Omnibus testing revealed significant DIF only for age (χ2=86.9, P<0.001); neither sex (χ2=31.7, P=0.063) nor treatment (χ2=22.4, P=0.379) showed evidence of DIF. Four items flagged for age-related DIF: self-care, usual activities, pain/discomfort, and anxiety/depression. However, only self-care (sWABC=-0.46) and usual activities (sWABC=-0.34) showed moderate effects, while pain/discomfort (sWABC=-0.002) and anxiety/depression (sWABC=0.09) were negligible. Importantly, factor scores from models with and without DIF adjustment correlated (correlation coefficient=0.98). CONCLUSIONS: The 5-level EuroQOL questionnaire appears to function equivalently across sex and treatment groups in this stroke population. Age-related DIF, though statistically detectable in physical functioning items, had little practical consequence for individual scores, supporting the instrument's use for health-related quality of life comparisons in stroke trials. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03889249.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Arimoro OI, Ademola A, Hill MD, et al. Evaluating Differential Item Functioning in EQ-5D-5L in Acute Ischemic Stroke: Evidence From the ACT Trial. Stroke. 2026. PMID: 42488952. doi:10.1161/STROKEAHA.126.055939

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。